Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 15.05
+0.12 (0.80%)
Apr 29, 2026, 3:13 PM CST
SHE:300122 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 36,027 | 45,171 | 62,957 | 146,664 | 140,528 | 199,360 | Upgrade
|
| Market Cap Growth | -37.99% | -28.25% | -57.07% | 4.37% | -29.51% | -15.76% | Upgrade
|
| Enterprise Value | 45,882 | 57,047 | 68,773 | 148,099 | 139,912 | 195,638 | Upgrade
|
| Last Close Price | 15.05 | 18.87 | 26.30 | 58.88 | 56.01 | 79.02 | Upgrade
|
| PE Ratio | - | - | 31.19 | 18.17 | 18.64 | 19.53 | Upgrade
|
| Forward PE | 11.61 | - | 14.60 | 15.39 | 19.63 | 21.81 | Upgrade
|
| PS Ratio | 4.11 | 5.04 | 2.42 | 2.77 | 3.67 | 6.50 | Upgrade
|
| PB Ratio | 2.29 | 2.81 | 2.04 | 4.66 | 5.80 | 11.29 | Upgrade
|
| P/TBV Ratio | 2.42 | 2.96 | 2.06 | 4.71 | 5.89 | 11.53 | Upgrade
|
| P/FCF Ratio | 7.83 | 9.93 | - | 18.65 | 262.21 | 30.32 | Upgrade
|
| P/OCF Ratio | 7.04 | 8.74 | - | 16.30 | 70.65 | 23.43 | Upgrade
|
| PEG Ratio | - | - | - | 0.86 | 19.63 | 0.66 | Upgrade
|
| EV/Sales Ratio | 5.24 | 6.37 | 2.64 | 2.80 | 3.66 | 6.38 | Upgrade
|
| EV/EBITDA Ratio | - | - | 25.38 | 15.56 | 15.54 | 15.91 | Upgrade
|
| EV/EBIT Ratio | - | - | 29.42 | 16.09 | 16.09 | 16.41 | Upgrade
|
| EV/FCF Ratio | 9.97 | 12.54 | - | 18.84 | 261.06 | 29.75 | Upgrade
|
| Debt / Equity Ratio | 0.72 | 0.76 | 0.40 | 0.10 | 0.08 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 4.54 | 0.32 | 0.23 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 2.46 | 2.70 | - | 0.39 | 3.79 | 0.12 | Upgrade
|
| Net Debt / Equity Ratio | 0.61 | 0.60 | 0.31 | -0.10 | -0.02 | -0.20 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.92 | -3.83 | 3.56 | -0.35 | -0.06 | -0.28 | Upgrade
|
| Net Debt / FCF Ratio | 2.09 | 2.12 | -1.81 | -0.42 | -1.10 | -0.53 | Upgrade
|
| Asset Turnover | 0.23 | 0.22 | 0.52 | 1.20 | 1.13 | 1.35 | Upgrade
|
| Inventory Turnover | 0.64 | 0.61 | 1.22 | 4.59 | 3.31 | 2.92 | Upgrade
|
| Quick Ratio | 2.43 | 1.12 | 1.03 | 1.85 | 1.76 | 1.45 | Upgrade
|
| Current Ratio | 3.14 | 1.53 | 2.24 | 2.35 | 2.37 | 2.09 | Upgrade
|
| Return on Equity (ROE) | -64.05% | -62.83% | 6.48% | 28.95% | 35.99% | 78.81% | Upgrade
|
| Return on Assets (ROA) | -4.82% | -4.63% | 2.92% | 13.04% | 15.98% | 32.93% | Upgrade
|
| Return on Invested Capital (ROIC) | -11.69% | -9.12% | 6.10% | 30.68% | 39.78% | 85.55% | Upgrade
|
| Return on Capital Employed (ROCE) | -12.50% | -15.60% | 7.40% | 28.60% | 35.10% | 65.60% | Upgrade
|
| Earnings Yield | -41.04% | -32.59% | 3.21% | 5.50% | 5.37% | 5.12% | Upgrade
|
| FCF Yield | 12.77% | 10.07% | -8.49% | 5.36% | 0.38% | 3.30% | Upgrade
|
| Dividend Yield | 1.34% | - | 0.76% | 1.36% | 0.60% | 0.51% | Upgrade
|
| Payout Ratio | - | - | 125.23% | 11.02% | 13.46% | 8.44% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | 0.06% | 0.20% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Total Shareholder Return | 1.39% | 0.06% | 0.96% | 1.36% | 0.60% | 0.51% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.